By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its first-quarter revenues rose 22 percent, while it cut its net loss 58 percent.

The Redwood City, Calif.-based pharmacogenomics test maker brought in total revenues of $41.2 million for the three-month period ended March 31, compared to $33.9 million for the first quarter of 2009. It fell short of analysts' consensus estimate of $43.4 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.